Charles River Laboratories International Inc
NYSE:CRL

Watchlist Manager
Charles River Laboratories International Inc Logo
Charles River Laboratories International Inc
NYSE:CRL
Watchlist
Price: 186.29 USD 0.49% Market Closed
Market Cap: 9.5B USD
Have any thoughts about
Charles River Laboratories International Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one CRL stock under the Base Case scenario is 299.7 USD. Compared to the current market price of 186.29 USD, Charles River Laboratories International Inc is Undervalued by 38%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CRL Relative Value
Base Case
299.7 USD
Undervaluation 38%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.3
P/S
P/S
Price to Sales
2.3
vs History
93
vs Industry
58
Median 3Y
2.8
Median 5Y
3
Industry
4.1
Forward
2.3
More Details
23.1
P/E
P/E
Price to Earnings
23.1
vs History
79
vs Industry
24
Median 3Y
24.3
Median 5Y
28.6
Industry
32.7
Forward
18.1
More Details
12
P/OCF
P/OCF
Price to OCF
12
vs History
95
vs Industry
35
Median 3Y
17
Median 5Y
17.2
Industry
22.1
More Details
36.4
P/FCFE
P/FCFE
Price to FCFE
36.4
vs History
30
vs Industry
14
Median 3Y
31.7
Median 5Y
22.7
Industry
33.6
More Details
2.5
P/B
P/B
Price to Book Value
2.5
vs History
96
vs Industry
30
Median 3Y
3.4
Median 5Y
4.3
Industry
2.6
More Details
2.9
EV/S
EV/S
Enterprise Value to Sales
2.9
vs History
95
vs Industry
48
Median 3Y
3.5
Median 5Y
3.6
Industry
3.9
Forward
2.9
More Details
8
EV/GP
EV/GP
Enterprise Value to Gross Profit
8
vs History
93
vs Industry
37
Median 3Y
9.4
Median 5Y
10
Industry
8.6
More Details
12.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12.2
vs History
95
vs Industry
34
Median 3Y
14
Median 5Y
15.6
Industry
18.5
Forward
11.2
More Details
19.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
19.1
vs History
88
vs Industry
25
Median 3Y
20.6
Median 5Y
22.9
Industry
23.7
Forward
15.2
More Details
14.6
EV/OCF
EV/OCF
Enterprise Value to OCF
14.6
vs History
96
vs Industry
33
Median 3Y
21.1
Median 5Y
21.2
Industry
21.4
More Details
20.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
20.8
vs History
95
vs Industry
20
Median 3Y
39.7
Median 5Y
37.2
Industry
28.8
More Details
1.5
EV/IC
EV/IC
Enterprise Value to IC
1.5
vs History
95
vs Industry
46
Median 3Y
1.9
Median 5Y
2.1
Industry
2.4
More Details

Multiples Across Competitors

CRL Competitors Multiples
Charles River Laboratories International Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Charles River Laboratories International Inc
NYSE:CRL
9.5B USD 2.3 23.1 12.2 19.1
US
PerkinElmer Inc
LSE:0KHE
1.2T USD 455.6 4 876 1 538.7 3 279.1
US
Thermo Fisher Scientific Inc
NYSE:TMO
202.3B USD 4.8 33 21.4 30.6
US
Danaher Corp
NYSE:DHR
166.6B USD 7.8 42.8 26.9 40.4
KR
Samsung Biologics Co Ltd
KRX:207940
66.8T KRW 15.3 63.4 34.3 49.4
CH
Lonza Group AG
SIX:LONN
38.4B CHF 5.7 67 45.3 45.3
US
Agilent Technologies Inc
NYSE:A
38.8B USD 6 30.1 22.4 26.1
US
IQVIA Holdings Inc
NYSE:IQV
36.2B USD 2.4 25.8 14.2 21.6
US
Mettler-Toledo International Inc
NYSE:MTD
27B USD 7.2 34 24.3 27.2
US
West Pharmaceutical Services Inc
NYSE:WST
24B USD 8.3 48.3 32.2 40.5
CN
WuXi AppTec Co Ltd
SSE:603259
164.4B CNY 4.3 20.4 14.8 14.8

See Also

Summary
CRL intrinsic value, competitors valuation, and company profile.
DCF Valuation
CRL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CRL stock valuation using valuation multiples.
Wall Street Estimates
CRL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CRL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.